What is Idexx Laboratories's remainder of fiscal year 2024?

Idexx Laboratories (IDXX) reported remainder of fiscal year 2024 of $23.63M in Q1 2026.

How has Idexx Laboratories's remainder of fiscal year 2024 changed year-over-year?

Idexx Laboratories's remainder of fiscal year 2024 increased by 10.4% year-over-year, from $21.41M to $23.63M.

Idexx Laboratories IDXX Remainder of Fiscal Year 2024

Remainder of Fiscal Year 2024 at other companies

ZoetisZTS

——

Bio-Rad LaboratoriesBIO

——

Agilent TechnologiesA

——

AbbottABT

——

RevvityRVTY

——

VeracyteVCYT

——

Other financials

Income statement

See full

Revenue$1.1B+14.3%

Gross profit$722.7M+15.9%

Operating income$362.6M+14.5%

Net income$278.4M+14.7%

EPS (diluted)$3.47+17.2%

Balance sheet

See full

Cash & equivalents$200.5M+22.3%

Total debt$575.5M-22.2%

Total equity$1.6B+7.5%

Total assets$3.4B+5.3%

Cash flow

See full

Operating cash flow$266.2M+11.9%

CapEx$32.0M+6.5%

Free cash flow$234.3M+12.7%

Valuation

See full

Market cap$41.53B+3.7%

Enterprise value$41.9B+3.3%

P/E37.9×-2.7×

P/S9.3×-0.6×

Profitability

See full

Gross margin62.1%+0.8pp

Operating margin31.6%+2.5pp

Net margin24.6%+1.9pp

FCF margin24.4%+2.8pp

Returns & leverage

See full

Return on equity72.9%+13.6pp

Debt / equity0.4×-0.1×

Current ratio1.1×0.0×

Where this comes from

Reported directly by Idexx Laboratories in its filing.

Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear.

The official record: Idexx Laboratories’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Idexx Laboratories's remainder of fiscal year 2024.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Idexx Laboratories's remainder of fiscal year 2024?: Idexx Laboratories (IDXX) reported remainder of fiscal year 2024 of $23.63M in Q1 2026.
How has Idexx Laboratories's remainder of fiscal year 2024 changed year-over-year?: Idexx Laboratories's remainder of fiscal year 2024 increased by 10.4% year-over-year, from $21.41M to $23.63M.